Ursotwincapsules are an effective oral medication containing the active ingredient ursodeoxycholic acid (UDCA) at a concentration of 500 mg per capsule. Ursodeoxycholic acid is a naturally occurring bile acid found in small amounts in human bile. When taken as a medication, it plays an important role in treating a variety of gallbladder, bile duct, and liver diseases by altering the composition of bile and facilitating its flow. Ursotwin is a valuable treatment option for individuals suffering from gallstone problems or certain chronic biliary diseases.
The active ingredient in Ursotwin capsules
Each Ursotwin capsule contains the following active ingredient responsible for its therapeutic effect:
Ursodeoxycholic acid: 500 mg. This dosage is commonly used in the treatment of many gallbladder and liver conditions, and may be adjusted based on the patient's response and the physician's recommendations.
Available Strengths
Ursotwin capsules are typically available in the following strengths:
Ursodeoxycholic acid: 500 mg.
Other strengths of ursodeoxycholic acid may be available under different brand names, such as 250 mg, to meet different patient needs based on the specific medical condition, age, and weight of the patient. The physician determines the appropriate strength and dosage based on a clinical assessment of each individual case.
Ursotwin capsules indications
Ursotwin capsules are primarily used to treat the following conditions:
Dissolution of small, asymptomatic cholesterol gallstones: Ursodeoxycholic acid reduces cholesterol excretion into the bile and helps dissolve small cholesterol stones that have not yet caused symptoms. However, it may not be effective in dissolving all types of gallstones, especially those containing high calcium or bile pigments.
Treatment for primary biliary cholangitis (PBC): A chronic autoimmune liver disease that progressively damages the bile ducts in the liver. Ursodeoxycholic acid helps slow the progression of this disease, improve liver function, and reduce symptoms in some patients.